Bisoprolol Fumarate And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71335-2589

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bisoprolol Fumarate And Hydrochlorothiazide (NDC 71335-2589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structurebisoprolol.jpg (Image 01)

Chemical structure of Bisoprolol Fumarate, showing two bisoprolol molecules associated with fumaric acid. The structure highlights a chiral center in the bisoprolol molecule.*

FDA Label Image

Structurehctz.jpg (Image 02)

Chemical structure diagram of Bisoprolol Fumarate and Hydrochlorothiazide, showing the molecular arrangement with chlorine, sulfur, nitrogen, and oxygen atoms in the compound.*

FDA Label Image

Label (Lbl713352589)

Label for Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP 5 mg/6.25 mg, film-coated tablet oral dosage form. The label shows the NDC 71335-2589-1, repackaged by Bryant Ranch Prepack, and manufactured by Glenmark Pharmaceuticals Limited. It includes handling instructions and storage conditions, highlighting a package size of 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.